Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Tezspire met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps
Friday, November 08, 2024Positive highlevel results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps CRSwNP nasal polyps showed that AstraZeneca and Amgens Tezspire tezepelumab demonstrated a statistically significant and clinically...
IotaSciences Launches New Single-Cell Cloning Platform XT to Further Increase Throughput and Speed for Cell Biology & Gene Therapy Applications
Wednesday, November 06, 2024IotaSciences the Oxfordbased leader in singlecell biology handling solutions announced today the upcoming launch of its newly developed SingleCell Cloning Platform XT at the Cell event in London UK from November
Olon is ready to host productions in the new facility dedicated to ultra-potent compounds
Tuesday, November 05, 2024Olon API provider and CDMO global player confirms the schedule for the construction of its new facility dedicated to ultrapotent compounds in Rodano Milan and to have already successfully completed the installation and validation of the new Small Sca...
Transgene and ProBioGen Join Forces to Advance Individualized Cancer Vaccine Development
Tuesday, November 05, 2024Transgene a biotech company that designs and develops virusbased immunotherapies for the treatment of cancer and ProBioGen a leading CDMO in biologics vaccines and viral vectors announce that the companies have entered into a license agreement for Pr...
Tessellate BIO Announces Appointment of Lara Boyd as Chief Business Officer
Monday, November 04, 2024Tessellate BIO a preclinical stage biotechnology company with a focus on novel Synthetic Lethality approaches today announces the appointment of Dr Lara Boyd as Chief Business Officer Lara joins Tessellate BIO from Fstar Therapeutics
Teva Presents New Tardive Dyskinesia Data at Psych Congress 2024 from the IMPACT-TD Registry, Revealing Differences in Patient Experience Based on Underlying Psychiatric Condition
Saturday, November 02, 2024Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA today announced new patient and physicianreported interim results from the Phase IMPACTTD Registry study revealing differences between TD patients with a ps...
Klöckner Pentaplast Launches kpNext® MDR1: Sustainable Medical Device Packaging Film
Friday, November 01, 2024Klckner Pentaplast kp a global leader in sustainable protective packaging is proud to announce the launch of kpNext MDR a new medical device packaging film that expands its kpNext brand beyond pharmaceutical blister films and into the medical device...
Lundbeck announces positive results from phase III pivotal trial (SUNRISE) of Vyepti® (eptinezumab) in migraine prevention
Friday, November 01, 2024H Lundbeck AS Lundbeck announced that Vyepti eptinezumab met the primary and all key secondary endpoints in SUNRISE a phase III pivotal clinical trial predominantly conducted in Asia evaluating the efficacy and safety in patients with chronic migrain...
IotaSciences Reports on Validation of New isoPick™ Single-Cell Picking Platform for Automated and Accessible Microfluidic Workflow for Single-Cell Lipidomics
Friday, November 01, 2024IotaSciences the Oxfordbased leader in singlecell biology handling solutions announced today the publication of validation work related to the use of its isoPick SingleCell Picking Platform for an automated and accessible microfluidic workflow for si...
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024
Friday, November 01, 2024Tonix Pharmaceuticals Holding Corp a clinicalstage biopharmaceutical company with marketed products and a pipeline of development candidates presented data in an oral presentation at the World Vaccine CongressEurope held October in Barcelona Spain...
